{"id":6462,"date":"2021-11-18T12:47:05","date_gmt":"2021-11-18T12:47:05","guid":{"rendered":"https:\/\/www.adacyte.com\/?post_type=scientific-corner&p=6462"},"modified":"2024-05-02T09:38:26","modified_gmt":"2024-05-02T07:38:26","slug":"granulocyte-and-monocyte-macrophage-apheresis-for-the-treatment-ofimmune-mediated-inflammatory-arthropathies-case-reports","status":"publish","type":"scientific-corner","link":"https:\/\/www.adacyte.com\/de\/professional\/scientific-corner\/granulocyte-and-monocyte-macrophage-apheresis-for-the-treatment-ofimmune-mediated-inflammatory-arthropathies-case-reports\/","title":{"rendered":"Granulocyte and monocyte\/macrophage apheresis for the treatment of immune-mediated inflammatory arthropathies: case reports"},"content":{"rendered":"
\n

Carro Mart\u00ednez AV, Montolio Chiva L, Robustillo Villarino M. Drugs Context. 2021;10:2021-8-5. https:\/\/doi.org\/10.7573\/dic.2021-8-5<\/p>\n<\/div>\n\n

\n

Drug therapy of immune-mediated inflammatory arthropathies is not always satisfactory, and there is a risk of adverse events. Granulocyte and monocyte\/macrophage apheresis (GMA) is a non-pharmacological therapeutic option that is beneficial and very well tolerated. GMA involves passing blood through a column with cellulose acetate beads to remove increased and activated myeloid lineage cells and improve the cytokine profile. The technique reduces pain and inflammation. We present four clinical reports that illustrate the clinical uses of GMA with the medical device Adacolumn\u00ae in patients with different backgrounds and immune-mediated inflammatory arthritis. The results were positive, and no adverse events were reported..<\/p>\n<\/div>\n\n

\n

dic.2021-8-5.pdf (drugsincontext.com)<\/a><\/p>\n<\/div>","protected":false},"excerpt":{"rendered":"

Carro Mart\u00ednez AV, Montolio Chiva L, Robustillo Villarino M. Drugs Context. 2021;10:2021-8-5. https:\/\/doi.org\/10.7573\/dic.2021-8-5 Drug therapy of immune-mediated inflammatory arthropathies is not always satisfactory, and there is a risk of adverse events. Granulocyte and monocyte\/macrophage apheresis (GMA) is a non-pharmacological therapeutic option that is beneficial and very well tolerated. GMA involves passing blood through a column […]<\/p>\n","protected":false},"template":"","scientific_tags":[337,193,276,107,80,453,336],"class_list":["post-6462","scientific-corner","type-scientific-corner","status-publish","hentry","scientific_tags-apheresis","scientific_tags-arthropathy","scientific_tags-cases","scientific_tags-monocyte","scientific_tags-psoriatic-arthritis","scientific_tags-rheumatoid-arthritis","scientific_tags-rheumatology"],"acf":{"sc_authors":"https:\/\/www.drugsincontext.com\/wp-content\/uploads\/2021\/11\/dic.2021-8-5.pdf<\/a>"},"yoast_head":"\nGranulocyte and monocyte\/macrophage apheresis for the treatment of immune-mediated inflammatory arthropathies: case reports - Adacyte<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.adacyte.com\/professional\/scientific-corner\/granulocyte-and-monocyte-macrophage-apheresis-for-the-treatment-ofimmune-mediated-inflammatory-arthropathies-case-reports\/\" \/>\n<meta property=\"og:locale\" content=\"de_DE\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Granulocyte and monocyte\/macrophage apheresis for the treatment of immune-mediated inflammatory arthropathies: case reports - Adacyte\" \/>\n<meta property=\"og:description\" content=\"Carro Mart\u00ednez AV, Montolio Chiva L, Robustillo Villarino M. Drugs Context. 2021;10:2021-8-5. https:\/\/doi.org\/10.7573\/dic.2021-8-5 Drug therapy of immune-mediated inflammatory arthropathies is not always satisfactory, and there is a risk of adverse events. Granulocyte and monocyte\/macrophage apheresis (GMA) is a non-pharmacological therapeutic option that is beneficial and very well tolerated. GMA involves passing blood through a column […]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.adacyte.com\/professional\/scientific-corner\/granulocyte-and-monocyte-macrophage-apheresis-for-the-treatment-ofimmune-mediated-inflammatory-arthropathies-case-reports\/\" \/>\n<meta property=\"og:site_name\" content=\"Adacyte\" \/>\n<meta property=\"article:modified_time\" content=\"2024-05-02T07:38:26+00:00\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Gesch\u00e4tzte Lesezeit\" \/>\n\t<meta name=\"twitter:data1\" content=\"1\u00a0Minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/www.adacyte.com\/professional\/scientific-corner\/granulocyte-and-monocyte-macrophage-apheresis-for-the-treatment-ofimmune-mediated-inflammatory-arthropathies-case-reports\/\",\"url\":\"https:\/\/www.adacyte.com\/professional\/scientific-corner\/granulocyte-and-monocyte-macrophage-apheresis-for-the-treatment-ofimmune-mediated-inflammatory-arthropathies-case-reports\/\",\"name\":\"Granulocyte and monocyte\/macrophage apheresis for the treatment of immune-mediated inflammatory arthropathies: case reports - Adacyte\",\"isPartOf\":{\"@id\":\"https:\/\/www.adacyte.com\/#website\"},\"datePublished\":\"2021-11-18T12:47:05+00:00\",\"dateModified\":\"2024-05-02T07:38:26+00:00\",\"inLanguage\":\"de\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/www.adacyte.com\/professional\/scientific-corner\/granulocyte-and-monocyte-macrophage-apheresis-for-the-treatment-ofimmune-mediated-inflammatory-arthropathies-case-reports\/\"]}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.adacyte.com\/#website\",\"url\":\"https:\/\/www.adacyte.com\/\",\"name\":\"Adacyte\",\"description\":\"Adacyte Therapeutics\",\"publisher\":{\"@id\":\"https:\/\/www.adacyte.com\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.adacyte.com\/?s={search_term_string}\"},\"query-input\":\"required name=search_term_string\"}],\"inLanguage\":\"de\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/www.adacyte.com\/#organization\",\"name\":\"Adacyte\",\"url\":\"https:\/\/www.adacyte.com\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"de\",\"@id\":\"https:\/\/www.adacyte.com\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/www.adacyte.com\/wp-content\/uploads\/2021\/01\/logo-adacyte.svg\",\"contentUrl\":\"https:\/\/www.adacyte.com\/wp-content\/uploads\/2021\/01\/logo-adacyte.svg\",\"width\":165,\"height\":46,\"caption\":\"Adacyte\"},\"image\":{\"@id\":\"https:\/\/www.adacyte.com\/#\/schema\/logo\/image\/\"}}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Granulocyte and monocyte\/macrophage apheresis for the treatment of immune-mediated inflammatory arthropathies: case reports - Adacyte","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.adacyte.com\/professional\/scientific-corner\/granulocyte-and-monocyte-macrophage-apheresis-for-the-treatment-ofimmune-mediated-inflammatory-arthropathies-case-reports\/","og_locale":"de_DE","og_type":"article","og_title":"Granulocyte and monocyte\/macrophage apheresis for the treatment of immune-mediated inflammatory arthropathies: case reports - Adacyte","og_description":"Carro Mart\u00ednez AV, Montolio Chiva L, Robustillo Villarino M. Drugs Context. 2021;10:2021-8-5. https:\/\/doi.org\/10.7573\/dic.2021-8-5 Drug therapy of immune-mediated inflammatory arthropathies is not always satisfactory, and there is a risk of adverse events. Granulocyte and monocyte\/macrophage apheresis (GMA) is a non-pharmacological therapeutic option that is beneficial and very well tolerated. GMA involves passing blood through a column […]","og_url":"https:\/\/www.adacyte.com\/professional\/scientific-corner\/granulocyte-and-monocyte-macrophage-apheresis-for-the-treatment-ofimmune-mediated-inflammatory-arthropathies-case-reports\/","og_site_name":"Adacyte","article_modified_time":"2024-05-02T07:38:26+00:00","twitter_card":"summary_large_image","twitter_misc":{"Gesch\u00e4tzte Lesezeit":"1\u00a0Minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/www.adacyte.com\/professional\/scientific-corner\/granulocyte-and-monocyte-macrophage-apheresis-for-the-treatment-ofimmune-mediated-inflammatory-arthropathies-case-reports\/","url":"https:\/\/www.adacyte.com\/professional\/scientific-corner\/granulocyte-and-monocyte-macrophage-apheresis-for-the-treatment-ofimmune-mediated-inflammatory-arthropathies-case-reports\/","name":"Granulocyte and monocyte\/macrophage apheresis for the treatment of immune-mediated inflammatory arthropathies: case reports - Adacyte","isPartOf":{"@id":"https:\/\/www.adacyte.com\/#website"},"datePublished":"2021-11-18T12:47:05+00:00","dateModified":"2024-05-02T07:38:26+00:00","inLanguage":"de","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.adacyte.com\/professional\/scientific-corner\/granulocyte-and-monocyte-macrophage-apheresis-for-the-treatment-ofimmune-mediated-inflammatory-arthropathies-case-reports\/"]}]},{"@type":"WebSite","@id":"https:\/\/www.adacyte.com\/#website","url":"https:\/\/www.adacyte.com\/","name":"Adacyte","description":"Adacyte Therapeutics","publisher":{"@id":"https:\/\/www.adacyte.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.adacyte.com\/?s={search_term_string}"},"query-input":"required name=search_term_string"}],"inLanguage":"de"},{"@type":"Organization","@id":"https:\/\/www.adacyte.com\/#organization","name":"Adacyte","url":"https:\/\/www.adacyte.com\/","logo":{"@type":"ImageObject","inLanguage":"de","@id":"https:\/\/www.adacyte.com\/#\/schema\/logo\/image\/","url":"https:\/\/www.adacyte.com\/wp-content\/uploads\/2021\/01\/logo-adacyte.svg","contentUrl":"https:\/\/www.adacyte.com\/wp-content\/uploads\/2021\/01\/logo-adacyte.svg","width":165,"height":46,"caption":"Adacyte"},"image":{"@id":"https:\/\/www.adacyte.com\/#\/schema\/logo\/image\/"}}]}},"_links":{"self":[{"href":"https:\/\/www.adacyte.com\/de\/wp-json\/wp\/v2\/scientific-corner\/6462","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.adacyte.com\/de\/wp-json\/wp\/v2\/scientific-corner"}],"about":[{"href":"https:\/\/www.adacyte.com\/de\/wp-json\/wp\/v2\/types\/scientific-corner"}],"wp:attachment":[{"href":"https:\/\/www.adacyte.com\/de\/wp-json\/wp\/v2\/media?parent=6462"}],"wp:term":[{"taxonomy":"scientific_tags","embeddable":true,"href":"https:\/\/www.adacyte.com\/de\/wp-json\/wp\/v2\/scientific_tags?post=6462"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}